Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Enfermedad de Parkinson

3465 ARTíCULOS , VIENDO DEL 1 AL 15

PUBMED

Neuroprotective effects of Korean medicinal plants in animal model of Parkinson's disease.

Han BS, Kim KS, Kim YJ, Jung HY, Kang YM, Sohn MJ, Kim WG.

Planta Med. 2016 Dec;81(S 01):S1-S381. No abstract available.

0

0

0

PUBMED

Cortical phosphorylated α-Synuclein levels correlate with brain wave spectra in Parkinson's disease.

Caviness JN, Lue LF, Hentz JG, Schmitz CT, Adler CH, Shill HA, Sabbagh MN, Beach TG, Walker DG.

Mov Disord. 2016 Jul;31(7):1012-9. doi: 10.1002/mds.26621.

0

0

0

PUBMED

Dementia Predictors in Parkinson Disease: A Validation Study.

Anang JB, Nomura T, Romenets SR, Nakashima K, Gagnon JF, Postuma RB.

J Parkinsons Dis. 2016 Nov 30. [Epub ahead of print]

0

0

0

PUBMED

Quantifying Parkinson's disease finger-tapping severity by extracting and synthesizing finger motion properties.

Sano Y, Kandori A, Shima K, Yamaguchi Y, Tsuji T, Noda M, Higashikawa F, Yokoe M, Sakoda S.

Med Biol Eng Comput. 2016 Jun;54(6):953-65. doi: 10.1007/s11517-016-1467-z.

0

0

0

PUBMED

Mendelian Randomization - the Key to Understanding Aspects of Parkinson's Disease Causation?

Noyce AJ, Nalls MA.

Mov Disord. 2016 Apr;31(4):478-83. doi: 10.1002/mds.26492.

0

0

0

PUBMED

Multimodal MRI Evaluation of the MitoPark Mouse Model of Parkinson's Disease.

Cong L, Muir ER, Chen C, Qian Y, Liu J, Biju KC, Clark RA, Li S, Duong TQ.

PLoS One. 2016 Mar 22;11(3):e0151884. doi: 10.1371/journal.pone.0151884.

0

0

0

PUBMED

Association of body mass index and the depletion of nigrostriatal dopamine in Parkinson's disease.

Lee JJ, Oh JS, Ham JH, Lee DH, Lee I, Sohn YH, Kim JS, Lee PH.

Neurobiol Aging. 2016 Feb;38:197-204. doi: 10.1016/j.neurobiolaging.2015.11.009.

0

0

0

PUBMED

Evaluation of Speech Amplification Devices in Parkinson's Disease.

Andreetta MD, Adams SG, Dykstra AD, Jog M.

Am J Speech Lang Pathol. 2016 Feb;25(1):29-45. doi: 10.1044/2015_AJSLP-15-0008.

0

0

0

PUBMED

LRRK2 Kinase Inhibition as a Therapeutic Strategy for Parkinson's Disease, Where Do We Stand?

Taymans JM, Greggio E.

Curr Neuropharmacol. 2016;14(3):214-25. Review.

0

0

0

PUBMED

Contribution of Pro-inflammatory Cytokine Signaling within Midbrain Periaqueductal Gray to Pain Sensitivity in Parkinson's Disease via GABAergic Pathway.

Zhuang X, Chen Y, Zhuang X, Chen T, Xing T, Wang W, Yang X.

Front Neurol. 2016 Jul 25;7:104. doi: 10.3389/fneur.2016.00104.

0

0

0

PUBMED

Polylysine-modified polyethylenimine (PEI-PLL) mediated VEGF gene delivery protects dopaminergic neurons in cell culture and in rat models of Parkinson's Disease (PD).

Abid Sheikh M, Saeed Malik Y, Xing Z, Guo Z, Tian H, Zhu X, Chen X.

Acta Biomater. 2016 Dec 23. pii: S1742-7061(16)30717-6. doi: 10.1016/j.actbio.2016.12.048. [Epub ahead of print]

0

0

0

PUBMED

Autophagy and Alpha-Synuclein: Relevance to Parkinson's Disease and Related Synucleopathies.

Xilouri M, Brekk OR, Stefanis L.

Mov Disord. 2016 Feb;31(2):178-92. doi: 10.1002/mds.26477. Review.

0

0

0

PUBMED

α-Synuclein-carrying extracellular vesicles in Parkinson's disease: deadly transmitters.

Chistiakov DA, Chistiakov AA.

Acta Neurol Belg. 2016 Jul 29. [Epub ahead of print]

0

0

0

PUBMED

Nrf2: a modulator of Parkinson's disease?

Todorovic M, Wood SA, Mellick GD.

J Neural Transm (Vienna). 2016 Jun;123(6):611-9. doi: 10.1007/s00702-016-1563-0. Review.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy